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ABSTRACT
PARTICLE SIZE DEPENDENCE ON IMMOBILIZED MOLECULAR
SENSORS: ASSAY OF NUCLEIC ACID PROBES ATTACHED TO
PARAMAGNETIC PARTICLES
by
Celin Sunny
Nanotechnology is concerned with materials and systems whose structure and
components exhibit novel and significantly improved physical, chemical and
biological properties, phenomena and processes due to their nano scale size.
The transition from micro scale to nano scale leads to a number of changes in
physical properties, possibly including new physical principles, some of which may
be yet to be discovered. One of the major factors in this is the increase in ratio of
surface area to volume.
This thesis research uses the increase in ratio of surface area to volume property
of going from macro to micro to nano scale to pose the hypothesis that the increase in
surface area to volume ratio as particle size gets smaller improves the functionality of
immobilized molecular sensors.
In this thesis work we have successfully immobilized pseudo molecular beacons
to paramagnetic particles of different sizes and shapes. The research has surprisingly
concluded that the relationship between specific binding capacity and performance as
measured by fluorescence binding capacity or performance labeling did not correlate
inversely with particle sizes at fixed particle mass as originally postulated.
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CHAPTER 1
INTRODUCTION
The development of sensitive specific devices (e.g., molecular sensors) for the detection,
diagnosis and monitoring of diseases, drug discovery, environmental detection of
pollutants and/or biological agent has been an active area of research for the past four
decades. One of the most significant problems in developing reliable sensors is
controlling and reproducing attachment of macromolecules, particularly biomolecules to
inorganic substrates/materials.
This thesis research is designed to demonstrate the ability of nanotechnology to
develop tools that allow characterization and detection of single cells, single molecules
and single molecular events, e.g. DNA hybridization and protein-protein interactions etc.
This research work has successfully designed nucleic acid sequences as
pseudomolecular beacons and immobilized them to paramagnetic particles of different
sizes i.e. from 1 micron to ~ 9 micron. To different types of paramagnetic particles
spherical particles and comet shaped particles were evaluated for use as attachment
substrates. The oligos were immobilized using novel bioconjugation chemistry from
Aolulink Inc.
The long term goal of this work is to exploit the improved physical, chemical
and/or biological properties of materials in nano scale by gaining control of the structures
at atomic and molecular levels and learn to efficiently engineer smart devices.
This field of research requires attention to several emerging disciplines which are
discussed in the next chapter.
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CHAPTER 2
BACKGROUND
2.1 Nanobiotechnology
Nanobiotecimology is an emerging area of scientific and technological opportunity. It is
an area that brings together the field of nanotechnology and biotechnology.
Nanobiotecimology applies the tools and processes of nano/microfabrication to build
devices for studying biosystems. This field illustrates the interdisciplinary nature of the
thesis work, which incorporates elements of both nanotechnology and biotechnology.
2.2 Nanotechnology
Nano is a Greek prefix that defines the smallest (1000 times smaller than micrometer)
natural structures or materials and nanotechnology, a most recent and highly energized
discipline of science and technology that deals with manipulation and use of these
structures/materials typically having the dimensions up to 100 nm with superior
electrical, chemical, mechanical or optical properties [1].
One of the first to articulate futuristic nanotechnology concepts was nobel
laureate Richard Feynman. In late 1959 he presented a lecture at the California Institute
of technology titled "There is plenty of room at the bottom". He talked about the
principles of nanotechnology even before the word existed. In his talk Feynman exposed
his audience with a technological vision of extreme miniaturization.
The essence of nanotechnology is the ability to work at the molecular level, atom by
atom, to create relatively larger and more complex structures with fundamentally new
molecular organization. For development of commercial applications (as distinct from
2
3basic research), such new molecular organization ideally enables or provides a useful
function in which case the structure can be legitimately referred to as a "device".
The ability to engineer a nanoparticle, nanomaterial or nanodevice to utilize its
property of small size and increased surface area to volume ratio brings the possibility of
detecting a very small amount or low concentration of analyte molecules compared to
materials in the macro or micro scale.
Nanometer sized objects possess remarkable self-ordering and assembly
behaviors under the control of forces quite different from macro objects. These unique
behaviors are what make nanotechnology possible, and by increasing our understanding
of these processes, new approaches to enhancing the quality of human life will surely be
developed.
Nanotechnology is expected to transform our lives in this decade. As scientists
and engineers exploit the tools of nanotechnology to design closer to the molecular level,
nanoscale materials engineering will have an increasingly important impact on a number
of sectors, including biotechnology, electronics, energy, and industrial products.
Nanotechnology should let us make almost every manufactured product faster, lighter,
stronger, smarter, safer and cleaner [2].
Examples of advances in the application of nanotechnology are Advanced
Computing — Nanoelectronic devices based on quantum dots, nano-wires and molecular
switches will enable next-generation computer chips, Cancer Treatment — Nanoparticles
are being developed for the targeting and destruotin of breast cancer cells, Energy
Atorage — Cathodes fabricated from nanomaterials promise rechargeable batteries with
longer lifetimes, Engineered Textiles — Nanofibers improve the properties of lightweight
4protective gear for public safety and defense professionals, Environment — Nanomaterial-
based photocatalysts clean the environment and yield surfaces with "self-cleaning"
properties, Packaging — Nanocomposite barrier plastics can increase the shelf life of
various foods and beverages, Pharmaceuticals — Antimicrobial nanocoatings on wound
dressings kill bacteria, reduce inflammation and promote healing.
The nanoscale offers the potential for orders of magnitude improvements in
sensitivity, selectivity, response time, and affordability. As surfaces get smaller there is
increased surface area to volume ratio. This thesis research is interested in the ability of
nanotechnology to develop tools that allow characterization and detection of single cells,
single molecules and single molecular events, e.g. DNA hybridization and protein-protein
interactions etc.
2.2.1 Nanomaterials
Nanomaterials have numerous commercial and technological applications, including
analytical chemistry; drug delivery; bioencapsulation; and electronic, optical, and
mechanical devices. In addition, this field poses an important fundamental question - how
do the electronic, optical, and magnetic properties of a nanoscopic particle differ from
those of a bulk sample of the same material? This issue is of particular importance
because all properties of a material change as the particle size approaches molecular
dimensions and because it is often the unique properties of the nanomaterial that make it
useful for a particular application [3].
The use of miniaturized solid-phase surfaces for hybridization analysis has
become increasingly more attractive for nucleic acid detection and analysis. Many
platforms utilize solid-support bound deoxyoligonucleotide probes to hybridize, and
5thereby capture, single-strand targets. Therefore, surfaces suitable for the immobilization
of DNA have become an increasingly important biological tool in recent years.
Hybridization of nucleic acid targets with tethered deoxyoligonucleotide probes is the
central event in the detection of nucleic acids on microarrays or other high-throughput
solid-phase-based assays. Choosing the correct surface as a solid phase is a critical step
in assay development. Molecules may be immobilized either passively through
hydrophobic or ionic interactions or covalently by attachment to activated surface groups.
Noncovalent surfaces are effective for many applications; however, passive adsorption
fails in many cases. Covalent immobilization is often necessary for binding molecules
that do not adsorb, adsorb very weakly, or adsorb with improper orientation and
conformation to noncovalent surfaces. Covalent immobilization may result in better
biomolecule activity, reduced nonspecific adsorption, and greater stability [4].
Arrays of DNA molecules, either as double-stranded segments or as short single-
stranded oligo-deoxyribonucleotides, have been utilized for drug development, DNA
sequencing, medical diagnostics, nucleic acid-ligand binding studies and DNA
computing. The principal advantages of using surface-bound oligonucleotide over those
in solution include ease of purification, conservation of material and reagents, reduction
of interference between oligonucleotides and facilitated sample handling. Previously
explored surfaces for immobilization of DNA include latex beads, polystyrene, carbon
electrodes, gold and oxidized silicon or glass. Each has unique surface characteristics that
can affect the performance of an assay [5].
The goal of surface modification is maximization of performance. The critical
assay parameters that determine the success of the surface modification and, ultimately,
6the commercial success of the assay are as follows [6]: (1) The ability to achieve targeted
sensitivity, (2) Maximum specificity with minimal nonspecific adsorption. (3) Adequate
reactions and kinetics of the ligand with its target molecule. (4) Atability of the ligand,
which increases reproducibility and extends shelf life. (5) Ease of use.
Aelection of the solid phase is also often influenced by the availability of
compatible instrumentation and robotic systems in research. Multiple-well polystyrene
plates have gained widespread acceptance in part because pipetting, washing, and its
signal detection are easily automated. Other advantages include the ability to analyze
multiple samples simultaneously and compatibility with a number of different detection
systems (e.g., colorimetric, fluorescent, and chemiluminescent).
2.2.2 Particles as Solid Supports
The application of small particles for in vitro diagnostics has been practiced for nearly 40
years. This is due to a number of beneficial factors including a large surface area to
volume ratio, and the possibility of ubiquitous tissue accessibility. In the last decade
increased investigations and developments were observed in the field of nanosized
magnetic particles (the term nanoparticle being used to cover particulate systems that are
less than in size, and normally below 500 nm).
The use of synthetic microparticles in bioanalysis originated in the mid-1950s,
with the invention of latex agglutination tests by Ainger and Plotz. These simple,
ingenious tests use suspended latex microparticles (diameter —1m) that are chemically
derivatized with a desired antibody. In early versions of this test, a drop of homogeneous
milky-white antibody-labeled suspension was applied to a glass slide and mixed with a
drop of the analyte solution. The analyte chemically links adjacent latex particles by
7binding to antibody sites on these particles, resulting in agglutination (or clumping
together) of the particles into what looks like curdled milk [3].
Magnetic particles offer some attractive possibilities in biomedical engineering.
They have controllable sizes ranging from a few nanometres up to tens of nanometres,
which places them at dimensions that are smaller than or comparable to those of a cell
(10-10011m), a virus (20-450nm), a protein (5-50nm) or a gene (2nm wide and 10-100
nm long). This means that they can 'get close' to a biological entity of interest. Indeed,
they can be coated with biological molecules to make them interact with or bind to a
biological entity, thereby providing a controllable means of 'tagging' or addressing it.
The nanoparticles are magnetic, which means that they obey Coulomb's law, and can be
manipulated by an external magnetic field gradient. This 'action at a distance', combined
with the intrinsic penetrability of magnetic fields into human tissue, opens up many
applications involving the transport and/or immobilization of magnetic nanoparticles, or
of magnetically tagged biological entities. In this way they can be made to deliver a
package, such as an anticancer drug or a cohort of radionuclide atoms, to a targeted
region of the body, such as a tumor. Third, the magnetic nanoparticles can be made to
resonantly respond to a time-varying magnetic field, with advantageous results related to
the transfer of energy from the exciting field to the nanoparticle. For example, the particle
can be made to heat up, which leads to their use as hyperthermia agents, delivering toxic
amounts of thermal energy to targeted bodies such as tumors; or as chemotherapy and
radiotherapy enhancement agents, where a moderate degree of tissue warming results in
more effective malignant cell destruction. These, and many other potential applications,
8are made available in biomedicine as a result of the special physical properties of
magnetic nanoparticles [7].
Advances in nanofabrication techniques are opening up a wide array of highly
sophisticated biomedical applications for smaller and smarter magnetic particles for use
in targeted drug delivery, ultra-sensitive disease detection, gene therapy, high throughput
genetic screening, biochemical sensing, and rapid toxicity cleansing. Each of these
disparate applications hinges on the apparently benign relationship between magnetic
fields and biological systems; field strengths required to manipulate nanoparticles have
no deleterious impact on biological tissue and the biotic environment does not shield
efforts to detect internal magnetism. This makes magnetic nanoparticles attractive as in
vivo probes or in-vitro tools to extract highly desired information on biochemical
system[8].
Over the past decade, a number of biomedical applications have begun to emerge
for magnetic micro- and nanoparticles of differing sizes, shapes, and compositions. Many
applications use iron oxide particles (usually Fe203 or Fe304. These particles are
available with diameters ranging from —300 nm to less than 10 nm for nanoscale
applications. They exhibit superparamagnetic behavior, magnetizing strongly under an
applied field, but retaining no permanent magnetism once the field is removed.
This onloff magnetic switching behavior is a particular advantage in magnetic
separation, one of the simplest applications. Magnetic separation is now well established
as a viable alternative to centrifugal separation of complex chemical or biological
solutions.
9To have practical utility in sensing devices, each paramagnetic particle (PIMP)
should also have surface properties that allow antibodies or recognition units to be linked
to the particles. For example: Iron oxide particles are first encased in a biocompatible
coating to form tiny beads. The beads are then `lunctionalized', that is, their surfaces are
treated with a biological or chemical agent known to bind to a specific target. Upon
placing the beads in solution, any target cells or molecules will latch onto the
functionalized surfaces. Figure 2.1 shows an iron oxide particle coated with a thin layer
of gold. The particle is functionalized using a sulphur group and a covalent bond is used
to attach this group to the gold surface.
A permanent magnet placed at the side of the solution beaker induces a magnetic
moment in each of the freely floating beads and sets up a field gradient across the
solution. The now-magnetized beads will move along the field lines and clump together
by the magnet, separating their bound targets from the bulk solution.
Figure 2.1 Iron Oxide Particle Coated with a Thin Layer of Gold.
A great deal of research is being done focusing on the use of magnetic
nanoparticles to design smart sensors. Paulo Freitas, professor of physics at the Institute
10
Superior Tecnico in Lisbon, has been conducting research on different superparamagnetic
iron oxide particles as markers for a table-top genetic screening device. The particles are
first functionalized with streptavidin, to enable binding of targets containing biotinyl
groups. A surface is prepared with a coating of biomolecular probes that will also bind
with complementary target species, creating a 'gene chip'. The intended end result is
similar to a sandwich: the target hybridizes with the fixed molecular probe and links to
the functionalized magnetic label. Its capture is recorded by magnetoresistive sensors
beneath the gene chip (Figure 2.2) [9].
Figure 2.2 Attachment of DNA Target to Immobilized DNA Probe.
Aensor development using magnetic, paramagnetic and superparamagentic
particles are still at a very early stage and many challenges remain. The tendency of Fe or
Co particles to aggregate would prevent a sensor from working effectively. Polymer-
coated iron oxide particles have the advantage of moving freely, but they have a far
smaller magnetic moment for their size. Micron-sized particles may impede biomolecular
11
recognition and interaction, hampering the sensor's efficacy, but particles smaller than
100 Om may prove difficult to detect individually [8].
2.3 Biotechnology
2.3.1 Biosensors
A Aensor is a device, which responds to an input quantity by generating a functionally
related output usually in the form of an electrical or optical signal. Aensor technology is
seen as an integral element in the overall development of products and services. In fact it
has emerged as a key technology to support a wide variety of research and industrial
applications. Aensor technology is an interdisciplinary technology. The development of
sensors combines the areas of physics, chemistry, advanced materials and molecular
biology with electronics and signal processing.
Biosensors are small devices which utilize biological reactions for detecting target
analytes. Auch devices intimately couple biological recognition elements (which interact
with the corresponding target analyte) with a physical transducer that translates the
biorecognition event into a useful electrical signal. Common transducing elements such
as optical, electrochemical or mass-sensitive devices generate light, current or frequency
signals, respectively. There are two types of biosensors, depending on the nature of the
recognition event. Bioaffinity devices rely on the selective binding of the target analyte to
a surface-confined ligand partner (e.g. antibody, oligonucleotide). In contrast, in
biocatalytic devices, an immobilized enzyme is used for recognizing the target substrate
(e.g. Aensor strips for personal monitoring of diabetes) [12].
Figure 2.3 	 Biosensors: The Intimate Coupling of Biorecognition and Aignal
Transduction.
A biosensor can be said to comprise of the following components: a biological
sensing element, a transducer and a data processor. The biosensor biological component
provides specificity: the ability to selectively recognize one type of chemical or event. Its
transducer confers sensitivity: the ability to transform the low energy of the biological
event into a measurable signal [13].
DNA biosensors, based on nucleic acid recognition processes, are rapidly being
developed with the goal of rapid, simple and inexpensive testing of genetic and infectious
diseases, and for the detection of DNA damage and interactions. Aequence-specific
hybridization biosensors rely on the immobilization of a single stranded DNA probe onto
the transducer surface. The duplex formation can be detected following the association of
an appropriate hybridization indicator or through other changes accrued from the binding
event.
There are many ways to detect DNA hybridization. Optical detection of DNA
hybridization is frequently used. The immobilized probe is usually tagged with a
fluorescent label. DNA optical biosensors commonly rely on a fiber optic to transduce the
emission signal of a fluorescent label. Walts group developed a fiber-optic DNA sensor
array for simultaneous detection of multiple DNA sequences. Hybridization of
13
fluorescently-labeled complementary oligonucleotides was monitored by observing the
increase in fluorescence that accompanied binding [18].
Yet another approach to DNA analysis taken by Vo-Dinh, is to design an array of
charge-coupled device (CCD) detectors and attach to their surface specific sequences of
DNA. Free DNA strands are labeled with fluorescent molecules and hybridized to the
bound DNA. When illuminated with laser light of the correct wavelength, the fluorescent
tags of the hybridized DNA emit light signals that are detected by the individual CCD
detectors behind each DNA site.
Each of the CCD pixels has a different but known short DNA sequence bound to
it, therefore the sequence of the piece of the longer DNA strand that hybridizes with the
short strand can be identified. By assembling all the information from the pixels, a larger
portion of the DNA sequence is obtained. Aince bacteria have unique DNA sequences,
these hybridization methods hold great promise as the basis for new techniques to rapidly
analyze DNA, characterize its source, and identify bacteria [19].
Fluorescence sensing remains the most widely used methodology in
biotechnology. Aeparation technologies, such as capillary array electrophoresis and
micro-array technology use fluorescent labeling for the detection of DNA and proteins.
Fluorescence detection offers exquisite sensitivity, specificity and compatibility with
standard biochemical reactions, such as polymerase chain reaction (PCR).
Traditional bio-fluorescence readers use bulky and discrete elements, which are
expensive and require a large footprint and precise alignment. The advantages of
integrated biological analysis systems are reduced when these systems rely upon large
and fragile optical sensing equipment. Integrated on-chip sensing architectures make
14
portable and robust medical care equipment practical. As a result of the recent explosion
in optoelectronics for telecommunications, a variety of interesting and useful integrated
optical sensing architectures can now be realized [5].
A different optical transduction, based on evanescent wave devices, can offer
real-time label free detection of DNA hybridization. These biosensors rely on monitoring
changes in surface optical properties (shift in resonance angle due to change in interfacial
refractive). Calorimetric DNA detection is another way to detect the DNA hybridization.
The plasmon resonance absorption of colloidal gold particles has recently been exploited
as a DNA-detection method.
Mirkin et al. attached 13-nm-diameter gold nanoparticles to single-stranded
oligonucleotides [17]. The plasmon resonance absorbance for these particles has a
maximum at 520 nm, and the particles appear red. When a linking oligonucleotide was
added, the gold nanoparticles agglutinated, and the color changed from red to purple. To
attach the single-stranded oligonucleotides to the gold nanoparticles, a gold sol was
stirred with a solution of terminally thiolated, 28 base-pair DNA. The first 13 nucleotides
served as a spacer from the nanoparticle surface; the last 15 were the recognition element
for the target. Two different recognition-element sequences were used The target DNA
was a 30 base-pair strand, the first 15 bases of which are complementary to the first
recognition element, and the remaining 15 complementary to the second recognition
element. When the target DNA was added to the modified colloidal suspension, the target
linked the individual colloid particles into a polymeric network. Because the
nanoparticles were now much closer together, the plasmon resonance band shifted, and
the color changed. Although this detection method had not yet been optimized, the
15
detection limit was 10fmol for the target oligonucleotide. An additional benefit of this
particular method is that it allows visual detection, especially if the sample is developed
on a solid support.
electronic devices for the electronic transduction of the formation of antigen—
antibody complexes on surfaces include the application of piezoelectric crystals, and
particularly quartz crystals, as a microgravimetric sensing device. The frequency change
of a quartz crystal (Aft), results from a mass change (Am) occurring on the crystal. Thus,
mass changes that occur on a quartz crystal as a result of the association of an antibody or
antigen, or the dissociation of an antigen—antibody complex by an analyte antigen, can be
microgravimetrically probed by a quartz crystal microbalance. For example, a maleimide-
monolayer-functionalized-gold-electrode was reacted with the anti-immunoglobulin
G(IgG) F(ab')2
 antibody that couples to the anti-Chlamydia trachomatis
lipopolysaccharide antibody. The latter interface specifically binds to the Chiamydia
trachomatis cells and the process is transduced by the microgravimetric assay of the
formation of the antibody—cell complex on the piezoelectric crystal [10].
Today's bioelectronic sensors generally consist of an electronic transducer whose
surface is engineered to support a biomolecule-bearing film, monolayer, or multilayer of
controlled thickness. Often, these substrates are functionalized with nucleic acids,
proteins, or ligands that recruit their binding partners through affinity interactions. The
electronic communication between the biomaterials and the respective transducers is the
essence of tailored bioelectronic devices.
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The electronic communication can proceed in two directions:
(a) the biological events, such as recognition or catalysis, which occur on the
transducer, might be reflected by an electronic signal leading to the formation of
electronic biosensors; or
(b) electronic signals, such as potential, might activate biological functions, such
as biocatalysis, thus enabling the development of electrically-driven
biotransformations [10].
Bioelectronics is a progressing interdisciplinary research field that involves the
integration of biomaterials with electronic transducers, such as electrodes, field-effect-
transistors or piezoelectric crystals. Aurface engineering of biomaterials, such as
enzymes, antigen—antibodies or DNA on the electronic supports, controls the electrical
properties of the biomaterial—transducer interface and enables the electronic transduction
of biorecognition events, or biocatalyzed transformation, on the transducers [10].
Biosensors of tailored sensitivities and specificities can be developed at the nano
scale using nano structures. The nanoscale should offer the potential for orders of
magnitude improvements in sensitivity, selectivity, response time, and affordability of
nansensors. Nanostructures, with their light-weight, small size and high surface-to-
volume ratio, will improve by orders of magnitude the capability to detect chemical,
biological, radiological, explosive (CBRE) agents with high sensitivity and selectivity.
Protective devices can be made to protect through filtration, adsorption, or neutralization
of agent leveraging on nanoporosity and high surface-to-volume of nanomaterials. With
nanotechnology the detection of a single CBRE entity comes within the realm of
possibility.
To build a nanosensor, nanotechnology can be utilized to fabricate a sensing area
that allows detection of binding events for only a few or single molecules. The procedure
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will be to selectively immobilize a binding agent on the sensor area, and to monitor the
change of the electrical, mechanical or optical properties of the "smart sensor" as a
function of the binding reaction with the target. Improved sensitivity will be a key
parameter in nanoscale assays, where minimum of sample and reagents are used. By
studying molecules and cells one by one, information is made accessible that would
otherwise be averaged out in standard population based assays.
2.3.2 DNA Probes
One of most specific molecular recognition or sensing event takes place when a strand of
nucleic acid anneals to its complement. A single-strand of oligonucleotide probe can find
a complementary strand in the presence of large excess of other nucleic acid. In order to
detect the hybridization reaction, either the probe has to be labeled or the target has to be
labeled.
DNA probes are single-stranded DNA or RNA. They hybridize to a target DNA
or RNA sequence. Probe and target base sequences must be similar to each other but,
depending on conditions, do not necessarily have to be exactly identical, i.e. their
complementarities is not always 100%. The probes must be labeled otherwise the
hybridization cannot be detected. DNA probes are used in various blotting and in situ
techniques for the detection of nucleic acid sequences. In medicine they can help in the
identification of microorganisms and the diagnosis of infectious, inherited and other
diseases.
Radiolabels and non-radioactive labels are the two kinds of probe labels. 32P, 35 A,
1251, 3H
 are used as radio isotope labels for nucleic acid probes and the labels detected by
autoradiography or Geiger-Muller counters. Radiolabeled probes are the most sensitive,
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e.g. 32P labeled probes can detect single-copy of a gene in only 0.5 ug of DNA. High
sensitivity means that low concentrations of probe-target hybrid can be detected.
However, radiolabeled probes less popular today because of safety considerations. Non-
radioactive labels are generally not as sensitive as radioactive labels. They are safer than
radiolabels and do not require dedicated rooms, glassware, equipment and staff
monitoring.
Aome examples of non-radioactive labels are (i) Enzymes: The enzyme is
attached to the probe and its presence usually detected by reaction with a substrate that
changes color e.g. alkaline phosphatase and horseradish peroxidase, (ii)
Chemiluminescence: In this method chemiluminescent chemicals attached to the probe
are detected by their light emission using a luminometer, (iii) Fluorescence: Chemicals
attached to probe fluoresce under UV light. (iv) Antibodies: An antigenic group is
coupled to the probe and its presence detected using specific antibodies. Also,
monoclonal antibodies have been developed that will recognize DNA-RNA hybrids. The
antibodies themselves have to be labeled, e.g. using an enzyme.
2.3.3 Molecular Sensors
Molecular sensor is a molecule, typically a biomolecule or biomemetic molecule that
performs two distinct functions in detecting target molecules. The first function is
specific binding, wherein the sensor molecule specifically recognizes a target molecule.
The second function is the generation of a target-dependent signal. The molecular sensor
used in this research is a pseudo molecular switch similar to the molecular beacons
invented by Kramer and Tyagi [16].
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2.3.4 Molecular Beacons
Molecular beacons are oligonucleotide probes that can report the presence of specific
nucleic acids in homogeneous solutions. As originally designed, a molecular beacon is a
single-stranded oligonucleotide probe containing a sequence complementary to the target
that is flanked by self-complementary termini, and carries a fluorophore and a quencher
at the 3'- and 5'-ends. In the absence of the target, these molecules form closed stem-loop
structures in which the fluorophore and quencher are in close proximity, which quenches
the fluorescence. In the presence of the target, the molecular beacon forms a complex
with its target, which dissociates the fluorophore from the quencher. Once the
fluorophore and quencher are spatially separated, the fluorescence increases and
quantitatively signals the presence of the target [16].
In order to design molecular beacons that function optimally under a given set of
assay conditions, it is important to understand how their fluorescence changes with
temperature in the presence and absence of their targets. At low temperatures molecular
beacons exist in a closed state, the flurophore and quencher are held in close proximity to
each other by hairpin system, and there is no fluorescence. At high temperature the
helical order of the stem gives way to a random-coil configuration, separating the
flurophore from the quencher and restoring fluorescence. The temperature at which the
stem melts depends upon the GC content and the length of the stem sequence. If a target
is added to a solution containing a molecular beacon at temperatures below the melting
temperature of its stem, the molecular beacon spontaneously binds to its target,
dissociating the stem, and become fluorescent. At low temperatures, the probe-target
hybrid remains fluorescent but as temperature is raised the probe dissociates from target
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and tends to return to its hairpin state, diminishing the fluorescence significantly. The
temperature at which the probe-target hybrid melts apart depends upon the GC content
and the length of the probe sequence.
Owing to their stem, the recognition of targets by molecular beacons is so specific
that single-nucleotide differences can be readily detected. Because of this property,
molecular beacons have been used for the detection of RNAs within living cells, for
monitoring the synthesis of specific nucleic acids in sealed reaction vessels, for
homogenous one-tube assays for genotyping single-nucleotide variations in DNA and for
multiplex PCR's for the detection of four different pathogenic retroviruses.
Figure 2.4 Achematic drawing of mechanism of signaling by molecular beacons.
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Figure 2.5 Design of a synthetic oligonucleotide for use as a molecular beacon target.
Capture via hybridization of nucleic acid targets by deoxyoligonucleotide probes
attached to a solid support surface is crucial for target detection on DNA microarrays and
other high-throughput solid-phase-based assays. Riccelli et al. studied the capture of
linear target DNA by hairpin and linear probes coupled to a solid support surface [14].
There were two inter-related components of the study. The first was to define standard
experimental parameters for performing hybridization assays on microtiter plates. This
required precise determination of the coating capacity of microtiter plate surfaces with
DNA probes and evaluation of the saturation (binding) capacity of the coated plates. The
second component of the study was to employ the developed and characterized assay
system to measure hybridization rates and stabilities of hairpin and linear capture probes.
The results show that target capture by hairpin probes is faster than with linear probes and
that, once formed; hairpin complexes are thermodynamically more stable. This is despite
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the fact that the coupling density on the surface for linear probes was nearly twice that for
hairpin probes. At 25 and 45°C and all target concentration examined, rates of
hybridization for hairpins are at least twice those of their linear probe counterparts.
Length of the single-stranded capture region was also found to affect target capture and in
general longer capture regions were favored.
2.4 Bioconjugation
Bioconjugation is defined as the linking of biomolecules to other biomolecules,
polymers, small molecules, surfaces or metals (Figure 2.7). Bioconjugation is a critical
enabling component of in vitro and in vivo diagnostics and in-vivo therapies.
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Bioconjugation requires identifying a conjugation scheme that forms a stable
linkage between the molecules, yet does not affect the inherent function of either
coupling partner. Examples of biomolecules used in conjugates include enzymes,
antibodies, peptides (synthetic and natural), oligonucleotides (synthetic and natural) and
carbohydrates. Other types of molecules widely conjugated to biomolecules include
fluorescent reagents, metal chelates and drugs. Yet another type of conjugation is the
attachment (immobilization) of biomolecules to solid surfaces such as plastics, glass,
metal aggregates and beads, which has broad applications in genomics, proteomics and
the diagnostic industry in general. For ideal bioconjugation to occur, first, the reactive
moieties (X) must react efficiently, yet must not crosslink with the biomolecule itself.
Aecond, the linkers (A and B) need to be reactive enough to couple with high efficiency,
yet stable enough so as to be stored in solution for long periods. Finally, the linkage
should be stable over broad pH and temperature ranges, while still allowing cleavability
to be introduced if desired. It is also extremely important that no non-specific (i.e.non-
covalent) binding/sticking of one biomolecule to the other biomolecule occurs which
would lead to high background interference in any assay. It would be further
advantageous if the functional reactive moieties (A and B) could be modified for
incorporation onto a biomolecule synthesized using standard solid phase methods.
There are three major bioconjugationlimmobilization methods in current use. One
is biochemical (biotin/avidin), and two are chemical (amine/active esters and
maleimide/thiol).
Avidin/Biotin: Biotin is a natural small-molecule ligand that binds to its protein receptor,
avidin (molecular weight 66 kD), with an extremely high binding affinity (1015 M).
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Biochemists have taken advantage of this high affinity by incorporating biotin onto one
biomolecule and conjugating avidin to another biomolecule, then coupling the two
conjugates together to form the final product.
Amine/Active Ester: Due to the limited stability of active esters in aqueous milieu the
amine/active ester conjugation couple has extremely limited utility. It is mainly used to
conjugate small molecules such as fluorophores to biomolecules such as proteins or
synthetic oligonucleotides.
Maleimide/Thiol: The maleimide/thiol couple has been used extensively in conjugating
biomolecules. Current ELIAA (enzyme linked immunosorbant assay) antibody-enzyme
conjugates are prepared using this method. A wide variety of conjugates used for in vivo
and in vitro applications have also been prepared using this chemical conjugation couple.
All three methods have serious inherent flaws that reduce their utility in many
bioconjugation applications. They do not fit the description for the ideal bioconjugation
couple mentioned above [15].
Figure 2.7 Biomolecule Modification.
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2.5 Immobilization using Solulink Chemistry
HydralinK is a novel bioconjugation system for the conjugation and immobilization of
peptides, proteins, carbohydrates, DNA and RNA. The technology is based on the
reaction of a 2-hydrazinopyridyl moiety with Benzaldehyde moiety to yield a stable bis-
aromatic hydrazone. The chemistry is highly selective, stable in solution and not
susceptible to non-specific binding, making it superior to conventional methods of
bioconjugation such as malemide/thiol and avid biotin.
The technique can be readily engineered to link small molecules (peptides,
flurophores), biomolecules proteins, DNA, RNA) or other molecules to solid surfaces
(glass, plastic, latex, silica beads), for application in proteonomics, genomics, drug
discovery, therapeutics and diagnostics. The implementation of the technology is
extremely simple. Benzaldehyde moiety on surfaces is effected by treatment with
succinimidyl 4-formylbenzoate. To introduce 2-hydrazinopyridine moiety is introduced
by using AANH.
Figure2.8 Modification of beads using AANH and AFB.
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Biomolecule modified with hydrazine and aldehyde modification reagents are
then mixed to give the hydrazone-mediated conjugate. The reaction is optimally carried
out at pH 4.7, but reaction also can occur up to 7.3, but the reaction will be very slow.
Figure 2.9 Bioconjugation of hydrazine and aldehyde modified moiety.
Advantages of the HydralinK bioconjugation system are: (1) Enhanced
stability of biomolecules modified with hydrazines and aldehydes leads to increased ease
of use, reproducibility and efficiency. The extended stability allows modified proteins to
be prepared days or weeks in advance of conjugation or immobilization and reaction
conditions to be optimized prior to scale up (2) The level of incorporation of both 2-
hydrazinopyridyl and benzaldehyde can be easily quantified spectrophotometrically (3)
The conjugation reaction is highly selective, eliminating non-specific interactions (4) Fast
reaction kinetics (5) Amenable to solid phase synthesis.
CHAPTER 3
RESEARCH OBJECTIVE
The purpose of the research is to combine emerging capabilities in nanotechnology and
biotechnology with the final aim of designing sensitive devices for detecting and
quantifying nucleic acid targets. The work done in this thesis is:
1. Design oligonucleotide sequences as pseudomolecular beacons.
2. Immobilize fluorescent labeled probe oligonucleotide nucleotide sequences
to paramagnetic particles using efficient immobilization chemistry.
3. Optimize the chemistry to get maximum probe attachment.
4. Analyze functionality of the probe by hybridizing target oligonucleotide sequence
to the immobilized particles.
5. Perform 1 and 2 on particles with different sizes and 2 different shapes (spherical,
irregular).
6. Atudy the effect of particle size on immobilization of molecular sensors.
The long term goal of this research work is to develop in-vitro sensors for
detection of biological targets.
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CHAPTER 4
EXPERIMENTS
4.1 Immobilization of FTBProbes to Microtiter Plate
Experimental Objective: To covalently immobilize fluorescently labeled amino linked
oligonucleotide nucleotide to glutaraldehyde modified BAA coated on black polystyrene
microtiter plate wells.
Reagents:
1. Coating Buffer = NaPO4 pH 7.0
2. Wash buffer = PBA Azide - 10mM NaPO4, 150mM NaC1, 0.25% NaN3 pH 7.1
(No Tween, No Aalt).
3. Bovine Aerum Albumin ( BAA)
4. FTBProbe-020203 :
5'- CGA TCG CGA CAT TCC ATC GTG CCC GAT CGA AAA A-3'
The oligonucleotide sequences were synthesized by MWG Biotech Inc.
5. Glutaraldehyde (GA)
6. Glycine
Steps:
1. The microtiter plate was coated with 200111 of varying concentration of BAAlwell
2. A Dilution Aeries for [BAA] was made according to table 4.1
3. The prepared plate was covered with Aaran wrap and incubated overnight at 2°C —
2°C. (4°C).
4. The BAA coated plate was washed after incubation overnight three times in wash
buffer.
Atock = 16.47mglml.
A Dilution was prepared for GA according to table 4.2
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Table 4.1 BAA Dilution Aeries for Microtiter Plate Adsorption
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5. GA dilutions were added at 100111lwell to the microtiter plate after the wash
procedure.
7. After overnight incubation, GA from plates was washed using PBA Azide wash
buffer.
8. Dilution series for FTBProbe was made.
Atock FTBProbe = 100 uM
Table 4.3 Dilution series for FTBProbe
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9. 50 pi of the prepared FTB dilutions was added according to designed protocol.
10. The plate was incubated overnight at
11. After overnight incubation, the plates were washed three times in PBA Azide
wash buffer.
12. 1 M glycine in NaPO4 10mM (pH 2.0) buffer was prepared. Glycine was added to
quench unreacted aldehyde with the amine group of the acid. 200[11 of
Glycine/well was added and incubated at room temperature for 1 hour. After
incubation, the plates were washed three times with PBA Azide (pH 7.1).
13. The microtiter plate was read at 5.0 volts in fluorolite 1000 microtiter plate reader
Experiment result:
The reading from the microtiter plate reader suggests that there is no significant
immobilization of FTB oligonucleotide probe to the microtiter plate. This could be
because of the low surface area offered for coating and binding by the microtiter plate
well. To get higher surface area, the substrate for immobilization was changed to
paramagnetic particles. The advantages of using the amine terminated biomag plus
particles or any paramagnetic particle over macro surfaces include:
1. Large surface area compared to microtiter plate.
2. Particles are already coated with silane amine group.
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4.2 Experiment 2
The objective of this experiment was to:
1. Immobilize the FTBProbe and unlabelled Target-NH2 onto the BioMag particles
using Glutaraldehyde Chemistry.
2. Hybridize the immobilized FTBProbe with a quencher and the immobilized
unlabelled Target-NH2 with a FTBProbe respectively.
4.2.1 Experimental Objective A: Immobilization of FTBProbe and unlabeled Target-
NH2 to 1 micron biomag plus particles.
Buffers:
1. 100m1 of 1M Dibasic Na2HPO4
2. 200m1 of 1M Monobasic NaH2PO4
0. 6700m1 of 1.1M NaPO4 pH 2.0— made using the Dibasic and Monobasic
Dilution Series:
1. FTBProbe — lOnmoles, 0.5nmoles, and inmoles
2. TBTarget-NH2 — inmoles, 1.67nmoles and 1.67nmoles
0. BioMag - 100011gl1.11, 2001.tg411, and 40µglµl
Materials:
1. FTBprobe-020203
2. Q-TBtarget-020203
0. 1 Micron paramagnetic particles from Polysciences
Experimental Procedure:
Immobilization was done using three concentrations each of oligonucleotide and target
and 2mg PMP particle for each condition at 12.67mg PMP/ml. i.e. 2* 6 = 12mg PMP was
needed. But double the amount of PMP was taken i.e. 2mg * (3 + 3) * 2 = 24mg PMP
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(approx 25mg PMP). Therefore 1.67ml was taken from the 670mg/ml stock PMP =
267mg/mll.
Steps:
1. 1.67m1 of Biomagplus PMP particles was taken and pipetted into a glass test tube
containing 67 ml of PH 2.0 buffer.
2. The test tube was then placed in a magnetic rack to separate the particles and the
residual buffer volume was decanted.
3. The paramagnetic particles were washed three times in 100mM NaPO4 pH 2.0
buffer.
4. While keeping the washed particles in the magnetic rack, 1.6ml of 100mM NaPO4
buffer was added. 400m1 of Glutaraldehyde (25%) was added to the test tube. The
tube was vortexed, capped and placed on a shaker. The tube was incubated in the
shaker for 5 hours.
5. After incubating for 67 hours, the particles were washed seven times in 100mM
NaPO4 pH 2.0 buffer.
6. After washing, the particles were resuspended in 2670111 of pH 2.0 buffer.
7. A dilution series of probel target was prepared as shown in table 2.1 and 2.2.
8. Concentration of stock FTBProbe = 100[1.M.
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2. 201.11 of 10mglm1 BioMagplus PMP was added to each of the six test tube
containing probe/target and the particles were allowed to separate in a magnetic
rack immediately.
3. While the tubes were in the magnetic rack 10p,1 of supernatant was withdrawn
from each tube. The supernatants were taken to give the input supernatant counts.
4. The 10[11 supernatant withdrawn was resuspended in 901.11 of 100mm NaPO4 pH
2.0 buffer (1/10 dilution of supernatant). This dilution allowed us to determine the
percentage of oligonucleotideltarget offered to the PMP for immobilization.
5. The six tubes with probeltarget with the BioMag were vortexed thoroughly and
were kept in the shaker at an angle for overnight incubation.
Post Immobilization Steps:
1) After Overnight incubation the tubes were taken off the shaker and put on the
magnetic separator rack. To get output counts, after the particles were fully
separated, 10[i1 of the supernatant was taken and diluted in 94.1 of 100mm
NaPO4 pH 2.0 buffer (1/10 dilution of output supernatant).
2) The immobilized particles were washed three times in lm 100mM NaPO4 pH 2.0
buffer.
3) After washing the particles were reconstituted in 200m1 of blocking buffer (PBA
Azide + BAA).
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4) 1ml of 1M Glycine (pH 2.0) was added to the tubes, vortexed and incubated in the
shaker for 1 hour.
5) After incubation, the particles were washed three times with 1ml 100mM NaPO4
(pH 2.0) buffer.
6) The particles with oligonucleotides immobilized were reconstituted in 200p1 of
blocking buffer (PBA Azide + BAA).
7) A dilution series for PMP particles was made with concentrations (100µg/ml, 200
µjtg/ml and 40tg/ml).
Figure 4.1 Titration Curve for GA Chemistry Based Probe immobilization on Particle.
Table 4.7 Input / Output data and dilution of glutaraldehyde activated FTB probe immobilized particles
1 2 3 4 5 6 7 8 9 10 11 12 ProtocolDilution
A
- 1297 341 293 133 252 109 162 347 149 213 669
Particle Dilution
40m/m140µg/ml
40pg/ml
Probe
B
B/P
- 1263 340 89 131 274 84 163 374 103 48 615
- 1385 418 321 139 298 116 170 416 719 218 633
D
- 1350 253 99 49 302 99 174 413 98 225 607 Concentrations
Al= lnmoleP3.33.3nmole
P10=10nmole
E /
/	 150 1425 376 450 158 327 103 184 496 101 243 682
F
O/C
155 1382 357 127 138 336 122 179 476 119 252 766
G 163 1375 382 443 178 365 116 191 CH8 8.92 130 239 801
H 162 1277 229 115 154 335 94 177 PH8.893 107 256 785
Reading, C1	 P3.3	 C10 C40
--------N.E._B40	 A100j 	 ,..C .40	 B40	 A1000--- C40-----Thz.
{IND;1.3ND}
B40	 A1009 50 Jul / Well
2.OVolts P1	 P3.3
VOLTAGE = 7 ; NO FILTER APPLIED
P10
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4.3 Optimization of Solulink Chemistry for Immobilization of Oligonucleotide to
Paramagnetic Particles of size 1 micron.
Objective: To optimize the amount of SANH to activate the paramagnetic particles and
the amount of AFB to activate the oligonucleotides and to test the effectiveness of the
probe based assay using quencher labeled targets.
4.3.1 Experiment (i):
Objective: Immobilization of fluorescently labeled oligonucleotide probes to PMP
particles using solulink chemistry and determining % of uptake of oligonucleotide by
measuring input and output supernatant counts.
Materials:
1. Paramagnetic particles from Polyscience of size 1 micron.
2. FTB- probe :
5'- CGA TCG CGA CAT TCC ATC GTG CCC GAT CGA AAA A -3'
3. Sodium phosphate buffer pH6.O
4. Sodium Phosphate/ Sodium Chloride buffer pH 7.2.
67. Solulink A-9002 HydralinK kit.
Experimental Procedure:
Particle preparation: Three batches of 10mg particle at 20mg/m1 were taken in three
test tubes to be activated with three varying concentrations of SANH per particle. The
number of amines per PMP for the 1 micron biomagplus particles is about
240umoles/gram.
Test Tube A: The condition in this test tube was decided to be 3eq SANH/ eq PMP —
NH2.
Test Tube B: The condition in this test tube was decided to be le RANH/ eq PMP — NH2
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Test Tube C: The condition in this test tube was decided to be 3.0eq SANH/ eq PMP —
NH2 .
All the particles were washed three times in pH 7.2 buffer by vortexing, magnetically
separating and decanting. After the final wash, test tubes 1, 2, and 3 were resuspended in
100pL of pH 7.2 phosphate buffer. Final concentration for all particles before activation
is 20mg/ml per condition.
Activation of particles: The particles were modified with a hydrazine linker using
SANH. According to solulink SANH was to be prepared at 67.67mg of RANH/ 100pL of
DMSO. To make 701AL of the RANH solution, 3.267mg of RANH was dissolved in 701.IL
of DMF. Care was taken to ensure that most of the SANH goes into solution. SANH was
added to the three test tubes with 2001AL of PMP solution in each according to the molar
ratio as shown in the table. The test tubes were then incubated on a shaker at room
temperature (20° — 267° C) for 2.67 hours
Oligonucleotide activation: FTBprobe-020203 oligonucleotide probe was used. The
oligonucleotide sequence was
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The stock oligonucleotide concentration was nmoles. For the purpose of this
experiment, the molar concentration of oligonucleotides taken is 1OHM i.e. 0.3 nmoles of
oligonucleotides.
Three test tubes labeled 1, 2 and 3 were taken and 33 111_, of stock oligonucleotide +
297u.1_, of buffer were added into each tube into each tube
Test Tube 1: The condition in this test tube was decided to be 10eq AFB/ eq
Oligonucleotide-NH 2 .
Test Tube 2: The condition in this test tube was decided to be 3Oeq AFB/ eq
oligonucleotides.
Test Tube 3: The condition in this test tube was decided to be 100eq AFB/ eq
oligonucleotides.
Molecular weight of AFB = 247.1
According to solulink chemistry, dissolve 4.2mg AFB in 100pL of DMSO. For activation
of 1 eq oligonucleotides with 10eq AFB we need 0.17RL of AFB. A stock solution
for 10eq AFB/eq oligonucleotides was prepared by mixing lmg AFB in 20.24, of
DMSO. A Dilution series from this stock solution of AFB + DMSO was prepared for
30eq AFB/eq oligonucleotides and 100eq AFB/eq oligonucleotides.
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The total reaction conditions were 330pL of (oligonucleotide + buffer) + 1.711,1, of
(DMSO + variable AFB). Test tubes 1, 2, and 3 were incubated at room temperature for
2.67 hours.
Purification of Oligonucleotide's after aldehyde modification: The AFB-
oligonucleotide reaction was terminated after 2.3 hours. The total reaction volume of
oligonucleotide+ AFB was about 330pL containing 0.5nmoles of oligonucleotide. The
oligonucleotides were purified by using a NAPS desalting column from Amersham
Biosciences. Three NAPS columns were used for purifying the three levels of
oligonucleotide activation with 3304 of oligonucleotide in each column. The columns
were first washed three times in pH 6.0 PO4 buffer by eluting and discarding elute. The
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column was allowed to drain completely and 3304, of oligonucleotide was carefully
added to the column. After the oligonucleotide had penetrated into the column, 340[11, of
buffer was added. The first elute was discarded. The column was carefully watched to see
the traveling of the oligonucleotide's to the tip of the NAPS coulmn.660pL of buffer was
again added to the column to elute the oligonucleotide band. Total volume of collected
oligonucleotide was 660tL in pH 6.0. The oligonucleotide was collected in a test tubes,
capped and stored in dark at 2° - 2°C. After purification, the oligonucleotide
concentration becomes 5uM.
Purification of particles: The RANH activated particles were removed from the shaker
after 2.67 hours. The particles were washed three times in pH 6.O buffer. After final wash,
the particles were resuspended in 4004 of pH 6.O buffer. The particles were at a
concentration of 267mg/mll.
Conjugation reaction (Immobilization of SFB activated oligonucleotide to SANH
activated particle): The hydrazine modified particles in test tubes A, B and C was
resuspended to 40011L after the final wash. Nine Test tubes were taken and labeled 1A,
1B, 1C, 2A, 2B, 2C, 3A, 3B and 3C. An optimization matrix was designed to compare
the low, middle, high concentrations of hydrazine modified paramagnetic particles times
the low, middle, high concentrations of aldehyde modified oligonucleotides.
80uL of activated PMP was added to the test tubes according to their designed
condition. The test tubes were placed in a magnetic rack. With the particles separated to
the sides of the tube, 210_, of the activated oligonucleotide was added according to table
4.13. The mixtures in test tubes 1A through 3C were vortexed and placed again placed in
a magnetic rack to separate the particles. After the particles were fully separated to the
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side, 224, of supernatant were removed from each PMP + oligonucleotide mixture and
diluted in 1924 of pH 6.0 buffer. The purpose of taking the supernatants were to get the
input counts of fluorescence at time 0 of the conjugation reaction. The immobilization
efficiency can be determined by calculating the % uptake of fluorescent oligonucleotide
from input and output supernatant counts. The supernatants were stored in properly
labeled centrifuge tubes in dark at room temperature. The test tubes with particles +
oligonucleotide were incubated overnight at room temperature in a shaker.
Post Conjugation steps: After incubating the particles for about 16 hours, the particles
were taken out from the shaker and place on a magnetic rack. The particles were allowed
to separate to the side of the test tubes. After about five minutes of separation, 36704 of
supernatant was withdrawn carefully to give the output counts after incubation. The
particles were then washed three times in PBA Azide + Tween wash buffer and then
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resuspended to 200uL in Immunoassay (PBA Azide + 2mg BSA) buffer. The final
concentration of the particles was calculated to l0mg/ml.
A protocol was designed to read the input and output counts from the supernatants
(in triplicates). 670uL of input and 50pL of output was pipetted into a 96 well microtiter
plate and read in a Fluorolite 1000 microtiter plate reader.
Another protocol was designed to read the counts for dilutions at each particle
preparation (in duplicates) at concentration ranging from 2000ug/ml to 101.1g/ml. A
dilution series for each particle was done and 1001AL of each dilution was pipetted into
the wells of a microtiter plate according to the designed protocol. The readings were
taken using a Fluorolite l000 microtiter plate reader.
Results
The readings of input and output counts suggest that the maximum uptake was in
condition 1A. There was about 40% uptake. This condition had the least SANH
activation and maximum AFB activation. At higher concentrations of RANH activation,
we notice very less uptake. This could be because for activating using Hi levels of SANH
we require more amount of DMSO and this could damage the particles. Since the amount
of DMSO added to the oligonucleotides is negligible even at hi concentrations of AFB
activation, we don't see the effect of DMSO at high AFB activation levels.
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Figure 4.3 Titration curve of Particles with FTBProbe using Different Activation Levels
of RANH and SFB.
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Table 4.16 I/P & 0/P of Biomag Plus at three different eq of RANH & AFB
1 2 3 4 5 6 7 8 9 10 11 12 ProtocolDilution
A 0 0 0 0 0 0 0 0 0 0 0 0 A= 1.0egSANH
eV.PNP-NH2
B
/
0 C0130054
C3
2107
3B
3440
3A
3694
2C
244
2B
2983
2A
3582
IC
1519
1B
2177
lA
2902 0
B= 1.0eqSANH
eV.PNC-NH2
0/P C013 C3 3B 3A 2C 2B 2A 1C 1B lA C= 1.0eqSANH
eV.PNP-NH2C 0 0053 488 3335 3743 2235 3163 3593 1459 2215 2852
0
D 0 C0120050
C3
2198
3B
3383
3A
3765
2C
2309
2B
3215
2A
3949
1C
1536
1B
2244
1A
2960 0
1= 100egSFB
AV
C012 C3 3B 3A 2C 2B 2A 1C 1B lA
2= 30egSFB
E 0 0045 339 340 336 316 323 364 258 266 266 0 eV
3= 10eqSFB
F i 0
C011
0033
C3
331
3B
334
3A
342
2C
330
2B
327
2A
364
1C
250
113
267
lA
272 0
eV
I/P S
G 0 C0110033
C3
339
3B
354
3A
338
2C
343
2B
347
2A
271
1C
256
1B
264
lA
287 0
H 0 0 0 0 0 0 0 0 0 0 0 0
Reading
VOLTAGE = 1.8 V
LAMC COMP. APCLIED
Table 4.17 Titration Curve of Particles at Different AFB and SANH Activation
1 2 3 4 5 6 7 8 9 10 11 12 ProtocolDilution
A 1567 1492 1206 1407 1617 1109 1000 1616 1278 - - 568 A= 1.0eqSANH
eV.CNP-NH2
B= 1.0egSANHB 850 847 717 726 745 644 720 800 666 - - 561
eV.PNP-NH2
C= 1.0eqSANHC 660 687 599 644 590 508 568 599 515 - - 525
eV.PNP-NH2
1= 100egSFBD 644 597 519 515 509 512 528 509 514 - - 550 eV
2= 10eqSFBE 697 657 508 619 526 504 499 548 526 - - 535 eV
0= 10egSFBF 684 580 500 512 489 491 490 481 502 - - 0809 eq
G 580 499 481 490 511 500 480 465 468 - - 0547
H 541 542 549 578 505 500 514 560 482 - - 0552
Reading	 1A 	 1B	 1C	 2A	 2B	 2C	 0A	 0B	 0C
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4.3.2 Experiment (ii):
Objective : To Determine the relative amount of fluorescently tagged oligonucleotide-
FTBProbe immobilized to the particles at varying probe and activation levels ( From (i))
as measured by direct fluorescent readings of particles at variable concentrations. The
performance of the fluorescent DNA probe assay is being tested by using quencher
labeled targets.
Materials:
1. Oligonucleotide immobilized particles from experiment (i)
2. Dilution buffer: 0.1M PO4 pH 6.0
0. Target with DABCYL quencher
Experimental Procedure:
1. Dilution series of PMP-FTBProbe was prepared as shown in table 4.14.
2. 1001.il of appropriate dilution of PMP-FTBProbe was pipeted into the wells of a
96 well microtiter plate. Dilution series of target oligonucleotide with DABCYL
quencher was prepared according to table 4.167.
3. 100111 of appropriate quencher or buffer was into the wells of the plate according
to the designed protocol.
4. The sides of the microtiter plate were tapped gently to mix the solutions in the
well.
5. The microtiter plate was wrapped securely and the plate was placed in a shaker
containing water. The temperature of the shaker is maintained at about 467 — 48°C.
6. The plates were incubated in the shaker overnight.
7. After overnight incubation, the plates were read in a microtiter plate.
Results: The data from this experiment confirms FTBProbe uptake from supernatant
after immobilization. The particle titration shows dose dependent fluorescence as a
function of particle concentration.
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Figure 4.4 Quench curve of Particles with FTBProbe using Different Activation Levels
of SANU and AFB.
Table 4.20 Uybridization Curve For Probe Immobilized Particles Using Solulink Chemistry
1 2 3 4 5 6 7 8 9 10 11 12 Protocol
A 0456 415 569 683 774 550 629 697 487 581 634 415
100uL [QT] in
each well
1001L [PMP] in
each well
Total Volume in
each well=200u1
B 0444 427 645 809 905 587 713 790 540 604 752 456
C 0457 445 674 851 948 616 773 838 552 704 801 458
D 0448 429 685 877 988 648 801 900 597 737 858 471
E 0460 452 745 947 1038 688
842 936 612 769 866 452
F 0440 454 833 1160 1130 731 907 948 634 835 908 481
G 0471 457 1327 1748 1323 1060 1384 1107 790 1104 1038 463
H 0472 0475 2111 2584 1846 1722 488 1604 1409 1851 1484 305
Reading
VOLTAGE = 7.5 V
TEMP - 45 ° bath
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4.3.4 Immobilization of Oligonucleotide's to Particles of Different Sizes
Objective: To immobilize oligonucleotide probe to particles of different sizes using
solulink chemistry.
Materials:
1. Paramagnetic particles from Apherotech of sizes 1.27 micron, 0.63 micron, 8.67
micron. Particles of 1 micron from Polyscience were taken as a control. Sample
particles from Polyscience of size 1 micron, 1.6 micron and 9.88 micron.
2. Solulink S-9002 HydralinK
3. FTBProbe :
5'- CGA TCG CGA CAT TCC ATC GTG CCC GAT CGA AAA A -3'
4. Sodium Phosphate/ Sodium Chloride buffer pH 7.8
5. PBA Abide/ Tween buffer pH 7.4
6. Sodium phosphate buffer pH6.0
7. PBA Azide buffer pH 7.4 + 2mg BSA
Experimental Procedure:
Particle preparation: Seven test tubes were taken and labeled 1, 2, 3, 4, 67, 6, 7
Test Tube 1: 1.27 micron particle from Apherotech. The particles were at a concentration
267mg/mll. To get 2mg of particles, 80111 of stock solution was pipetted it into 6700111 of pH
7.8 phosphate buffer.
Test Tube 2: 0.63 micron particles from Apherotech. The particles were at a concentration
25 mg!ml.
Test Tube 3: 8.67 micron particles from Apherotech. The particles were at a concentration
10mg/ml. To get 2mg of particles, 2000 of stock solution was pipetted it into 6700111 of
pH 7.8 phosphate buffer.
Test Tube 4: 1 micron particles from Polyscience. The particles were at a concentration
of 670mg/mll. To get 2mg of particles, 40p,1 of stock solution was pipetted it into 500111 of
pH 7.8 phosphate buffer.
Test Tube 67: 1.6 micron particles from Polyscience. The particles were at a concentration
of 10mg/ml. To get 2mg of particles, 40111 of stock solution was pipetted it into 100[11 of
pH 7.8 phosphate buffer.
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Test Tube 4: 9.6 micron particles from Polyscience. The particles were at a concentration
of 20mg!ml. To get 2 mg of particles, 400 of stock solution was pipetted it into 200[1.1 of
pH 7.8 phosphate buffer.
All the particles were washed three times in pH 6.O buffer by vortexing,
magnetically separating and decanting. After the final wash, test tubes 1, 2, 3, 4, 5, 6 and
7 were resuspended in 100vil of pH 7.8 phosphate buffer. Final concentration for all
particles before mixing of the oligonucleotide's is 20mg/ml
Activation of particles: The particles were modified with a hydrazine linker using
SANH. From the previous experiment (experiment 3) results it was decided to use 1.3eq
SANH/ eq PMP. It was noticed that the amine density on Apherotech particles is far less
than the amine density on biomag plus particles. Therefore the lowest effective SANH to
PMP ratio was used to ensure minimal use of DMSO. SANU was to be prepared at 5.5mg
of RANH/ 1001.11 of DMSO. 1.378[11 SANH/mg of PMP is needed. 0 .62mg of SANH
was added to 56.41..t1 of DMSO (This is at a 1/5 dilution). Care was taken to ensure that
most of the SANH goes into solution. 4.01_11 of the resulting solution was then added to
the test tubes 1, 2, 3, 4, 5, 6 and 7 which is at a PMP concentration of 2Omg/ml.
Therefore per test tube we had 4ul of SANH + DMSO and 81.11 of PMP + PH 7.8 buffer.
The test tubes were then incubated on a shaker at room temperature (20° — 25° C) for 2.5
hours.
Oligonucleotide activation: F- TBprobe-080803 oligonucleotide probe was used. The
oligonucleotide sequence was 5'- CGA TCG CGA CAT TCC ATC GTG CCC GAT
CGA AAA A-3'. The stock oligonucleotide concentration was 100 nmoles. The needed
mass of oligonucleotide was 7.Snmoles. 75[il of stock oligonucleotide and put it in 67411
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of buffer pH 7.8. The concentration of AFB required for activation is 4.8mg/100p1 of
DMSO. From previous experimental data it was decided to use 100eq AFB/ eq
oligonucleotide. 1.48mg of AFB was weighed and dissolve it 10tl of DMSO. 0.94Rl of
the resulting AFB solution was added to the oligonucleotides. The concentration of
oligonucleotides is CORM. The oligonucleotide + AFB were incubated for 2.5 hours at
room temperature.
Purification of Oligonucleotides after aldehyde modification: The AFB —
oligonucleotide reaction was terminated after 2.30 hours. The total reaction volume of
oligonucleotide+ AFB was about 720Rl containing 7.5 moles. The oligonucleotides were
purified by using a NAPS desalting column. Two NAP 5 columns were used for
purifying 375Rl of oligonucleotide in each column. The column was first washed 3 times
in pH 6.O PO4 buffer by eluting and discarding elute. 375pl of oligonucleotide was
carefully added to the column and after the oligonucleotide had penetrated into the
column, 375R1 of buffer was added. The first elute was discarded. 750111 of buffer was
again added to the column to elute the oligonucleotide band. Total volume of collected
oligonucleotide was 1.5ml. The oligonucleotide was collected in test tubes, capped and
stored in dark at 2° - 2°C. After purification, the oligonucleotide concentration becomes
5tM.
Purification of particles: The SANH activated particles was removed from the shaker
after 2.5 hours. The particles were washed three times in pH 6.0 buffer. After final wash,
the particles were resuspended in 80Rl of pH 6.O buffer. The particles were at a
concentration of 25mg.
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Conjugation reaction (Immobilization of SFB activated oligonucleotide to SANH
activated particle): The hydrazine modified particles in test tubes 1, 2, 3, 4, 5, 6 and 7
was resuspended to 80tl after the final wash. 200111 of aldehyde modified
oligonucleotides were added to each of the PMP preparations. The mixtures in test tubes
1, 2, 3, 4, 5, 6 and 7 were vortexed and placed in a magnetic rack to separate the particles.
After the particles were fully separated to the side, 22til of supernatant were removed
from each PMP preparation and diluted in 198[1.1 of pH 6.O buffer. The purpose of taking
the supernatants were to get the input counts of fluorescence at time 0 of the conjugation
reaction. The supernatants were stored in properly labeled centrifuge tubes in dark at
room temperature. The test tubes with particles + oligonucleotide were incubated
overnight at room temperature in a shaker.
Post Conjugation steps:
After incubating the particles for about 16 hours, the particles were taken out from the
shaker and place on a magnetic rack. The particles were allowed to separate to the side of
the test tubes. After about five minutes of separation, 220p1 of supernatant was
withdrawn carefully to give the output counts after incubation. The particles were then
washed three times in PBA Azide + Tween wash buffer and then resuspended to 2001.11 in
Immunoassay (PBA Azide + 2mg BSA) buffer. The final concentration of the particles
was calculated to 10mg/ml.
Microtiter Plate Assay
A protocol was designed to read the input and output counts from the supernatants (in
triplicates) and look at the dilutions of each particle preparation (in duplicates) at
concentration ranging from 2000pg/ml to 10pg/ml. A dilution series for each particle was
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done and 1000 of each dilution was pipetted into the wells of a microtiter plate
according to the designed protocol. The input and output supernatants were pipetted into
the wells at 10111 of respective input/output + 10p1 of buffer. The readings were taken
using a Fluorolite 1000 microtiter plate reader.
Experimental Results:
1. Apherotech Particles: The tiratrion curves for the Spherotech particles show no
variation in counts with increase in concentration of oligonucleotide immobilized
particles. Also no change in oligonucleotide immobilization with respect to
particle size was seen. The BiomagPlus control particles show a nice titration
curve.
2. BiomagPlus particles:
The titration curve for the BiomagPlus particles show the maximum counts for
6.O micron particles. The least counts are for the 1 micron particles. This is
counterintuitive to our hypothesis.
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Aft
Figure 4.6 Titration Curve for BiomagPlus Particles.
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Experiment Discussion:
The readings from the microtiter plate 1 give us the following conclusions
1. The input supernatant shows lower counts than the output supernatant.
The speculated reasons for this kind of a result could be (a) An effect of pH of the
dilutions of oligonucleotide with time (b) "Soaking" up of oligonucleotides at
time t = 0 which gives us low input counts when we take the supernatants at time t
= 0 (c) Some undetermined source of oligonucleotide contamination or
photobleaching?
2. The dilutions series of the oligonucleotide + Apherotech PMP shows that there is
no effective intake of oligonucleotide with change in PMP size and the counts are
comparable to the background, while the oligonucleotide + Polyscience PMP
control shows good variation in counts with dilutions. The Apherotech particles
are prepared by coating a layer of magnetite and polystyrene onto monodispersed
(i.e. uniform sized) polystyrene core particles. During the experimental
procedures, we noticed that there was particle loss during washing processes, the
particles did not separate well, and we could see films in the particle solution after
activation and oligonucleotide immobilization which seemed to look like
"coatings" of the particle. This raises the following question: (a) Has the amine
coating or magnetic layer of the particle been stripped off during the activation or
oligonucleotide immobilization. If yes then why? (b) Does pH have an effect on
the magnetite coating or amine termination of the Apherotech particle?
The readings from microtiter plate 2 shows the following results
1. As observed with the Apherotech particles, the i/p counts are much lower than the
o/p counts. The reason could be same as that speculated with Apherotech particles
i/p and o/p counts.
2. The Polyscience biomag particles are not spherical in shape. They are irregular,
comet shaped iron oxide particles. The dilution series done for the Polysciences
particles show a nice titration curve in contrast to the Apherotech particles. But the
data obtained is converse to the hypothesis. According to our hypothesis, we
would expect the 1 micron particles of Polyscience to show more fluorescent
oligonucleotide uptake than the 9.8 micron particles. But the results show that 9.8
micron particles have markedly more fluorescently labeled oligonucleotide's
immobilized to them than the 1 micron particle. The reasons could be
(a) As the particle size is decreasing, is some surface property of the particle
preventing immobilization of oligonucleotide to activated amine groups even
though there are more number of amine groups per volume on the 1 micron
particle than the 9.8 micron particle.
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(b) Effect of diffusion kinetics. We need to find out if there are more number of
binding events taking place inside the pores of the one micron particles than on
the 9.8 micron particles. If this is the case, then we will not be able to detect the
fluorescent oligonucleotides bound inside the pores.
(c) There is more number of particles per unit volume in the 1 micron particles
than in the 9.8 micron particle. As the particle size increases, the number of
particles per unit mass should decrease at least 1000 times (as with the case of
spherotech particles). Since there is more number of particles per unit volume or
mass, there could be more quenching of the fluorescence emitted by the
fluorescently tagged oligonucleotide than with the 9.8 micron. That is the particle
density per unit volume is going to contribute to signal quenching.
The sensitivity of the microtiter plate reader may not be good enough to detect the
signals emitted by the immobilized particles. The best way to detect the number of
oligonucleotides immobilized per surface area or per particle will be with AFM or with
flow cytometry. In order to find out why the data shows lesser number of input counts
than output counts, a time course study of fluorescence was conducted.
Table 4.22 Nate I — Apherotech + Polyscience 1 micron
1 2 3 4 5 6 7 8 9 10 11 12 ProtocolDilution
A I/PS1.27
256
I/P
S3.5
235
I/P
S8.5
238
I/C
P1
247
1238 1199 287 244 273 262 255 266 400 g/ml
B 186 188 234 176 742 720 238 237 259 244 254 256 1000lig/m1
C 208 257 183 194 596 561 243 229 220 233 250 255 500 utg/ml
D 40 181 176 188 391 399 237 231 226 226 239 228 40 uug/ml
E 0/PS1.27
2171
0/P
S3.5
2128
0/C
S8.5
2026
0/C
P1
2118
431 339 288 403 237 248 231 229 100 ptg/ml
F 2250 1989 2020 2708 297 287 336 249 233 233 239 236 50 ptg/ml
G 2432 2296 2217 2414 370 254 248 267 239 249 252 318 20 Kg/m1
H 2221 2880 2241 2397 254 251 264 251 267 263 296 246 On/m1
------Thr---"	 --------Thr
B1	 S8.5
0
-----"Thr------- 	 -----Thr----- 	50 Jul / Well
53.63	 S1.27
2	 1
100 p.1/ Well	 9.4 Volts
Reading
4.0Volts
3
'
Table 4.23 Plate II — Polyscience
1 2 3 4 5 6 7 8 9 10 11 12 ProtocolDilution
A B/CC1
B/C
C1.6
B/C
C6.0 Si Bkd 55 54 3246 3124 2896 2979 191 192 400 pg/ml
146 22 52 18
B B/CC1
B/P
P1.6
B/P
C6.0 14 50 49 2342 2323 1989 1964 120 126 1000 g/ml
201 25 57
C B/PP1
B/P
C1.6
B/P
P6.0 S2 Bkd 54 46 1554 1531 1199 1276 88 89 500 g/ml
166 27 51 15
D B/CP1
B/C
P1.6
B/P
C6.0 16 43 45 965 929 758 754 71 72 40 g/ml
180 29 55
E 0/CC1
0/P
C1.6
0/C
P6.0 P1 Bkd12 46 43 678 609
461 436 56 54 100 g/ml
191.4 344 439
F 0/PC1
0/C
P1.6
0/P
C6.0 11 44 46 392 376 294 292 52 55 50 g/m1
2155 417 530
G 0/PC1
0/P
P1.6
0/P
P6.0 P2 Bkd 53 43 201 158 139 128 61 50 20 g/ml
1928 331 461 12
H 0/CC1
0/P
C1.6
0/P
P6.0 15 62 54 64 62 62 64 54 56 0 pg/ml
1079 384 478
_.... ...____v. ... N.._._.__v____—/ ■ 	 _\( ../ ■ _, 100 [d / WellReading-- \r
4.1Volts 	 MBgG 	 P6.0 	 P1.6 C1.0
7 	 6 	 5 4
6.0 Volts
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4.3.5 Oligonucleotide Immobilization Time Course Study
Experimental Objective: To study the immobilization of oligonucleotides onto the
paramagnetic particles during different time points.
Materials:
1. Particles of 1 micron from Polyscience.
2. Solulink S-9002 HydralinK
4. Sodium Phosphate/ Sodium Chloride buffer pH 7.8
5. PBA Abide/ Tween buffer pH 7.4
6. Sodium phosphate buffer pH6.O
7. PBA Abide buffer pH 7.4 + 2mg BSA
Experimental Procedure:
Activation of 1 u Biomag plus particles
Particle Preparation: Atock PMP @ 10 mg/ml
10mg particles were activated. Therefore 1 ml of the stock PMP was taken and pipetted
into 3ml of 1.1M pH 7.8 buffer. The particles were washed three times in 5ml of 1.1M
pH 7.8 buffer. After washing, the particles were resuspended in 2.5ml of pH 7.8 0.1M
buffer to 2Omg!ml.
1. Particle activation using SANH:
Condition of activation = le RANH / leq PMP = 1.26[11 RANH / mg particle
63p1 of RANH / 10mg PMP is needed.
Solulink protocol: 5.5mg SANH / 100W DMSO. Therefore 4.4mg SANH was
dissolved in 80vil of DMSO
63111 of the prepared solution was added to the washed 20 mg!ml particles and
incubated in the shaker at room temperature for 2.5 hours.
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Post Incubation Ateps: After Incubation, the particles were removed from shaker.
The particles were washed four times in pH 6.O buffer and resuspend to 25 mg/mi
i.e. in 2 ml of pH 6.O buffer.
2. FTBProbe Activation using SFB
Probe: 5'- CGA TCG CGA CAT TCC ATC GTG CCC GAT CGA AAA A — 3'
Atock probe concentration = 10011M.
1 / 5 dilution of the oligonucleotide stock i.e. 20RM was made by adding 300vl of
stock oligonucleotide to 1200[1.l of buffer. The total volume of the resulting
oligonucleotide solution is 1500u1. (20uM x 1500111= 30 moles).
100eq AFB/ eq oligonucleotide — NH2 ratio was chosen for oligonucleotide
activation.
30 nmoles x 100eq AFB / eq oligonucleotide — NH2 = 3000 moles AFB. To
activate oligonucleotides with 3000 nmoles of AFB 15.78 ul of AFB is needed.
Solulink ratio: 4.8 mg AFB/ 100µl DMSO.
0 .88 mg AFB was weighed and dissolved in 20u1 DMSO. 15.78 IA prepared AFB
solution was added to 750111 prepared oligonucleotide solution. The
oligonucleotide's activated with AFB was incubated in room temperature for 2.5
hours.
After incubation, the oligonucleotides are purified using NAPS columns. For 1.5
ml of activated oligonucleotides, after purification through the desalting column, 0.0ml of
purified activated oligonucleotides is obtained. The resulting molar concentration will be
10iM.
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At each point two sample points from the master mixture tube is taken.
Sample 1 - To give reading of fluorescence of PMP + Oligonucleotide
Volume — 33111
Dilution — 33ul of sample + 297111 of pH 6.O buffer
Sample 2 — To give reading of amount of oligonucleotides in the supernatant amount of
oligonucleotide's immobilibed to the particle
Volume — 330
The sample was separated in a magnetic rack. 3411 of supernatant was carefully
withdrawn.
For (i) the supernatant withdrawn was diluted in 270ul of pH 6.O buffer
For (ii) the residual volume of particles + supernatant after removal of 301il of
oligonucleotide is diluted in 270111 of pH 6.O buffer.
After samples are taken till time point t=2 hours, the PMP + Oligonucleotide
master mixture is incubated overnight. After incubation 0/N, the master mixture is
separated in a magnetic rack and 600111 of supernatant is withdrawn. This would give us
the output counts.
The particles were washed three times in PBA Abide + Tween wash buffer and
then resuspended in Immunoassay (PBA Abide + 2mg BSA) buffer so that the final
concentration of is particles 10mg/ml. A dilution series for the oligonucleotide
immobilibed particle as shown in the table below and read at a constant voltage the
fluorescence count using fluorometer.
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Table 4.24 Dilution Series for Particles with Different Sibes for Titration of
Fluorescence
Tube # Concentration Atock Buffer
( pH 6.0)
Total Volume
A 40pg/ml 90[11 stock
activated
oligonucleotide
3601,11 440p1
B 1000pg/m1 1541A 150u1 540p1
C 50pg/m1 60g1 A 180u1 2441
D 40pg/ml 54u1 A 516p1 5441
E 10Oughn1 24u1 516111 540111
F 40pg/ml 24t1C 516111 540111
G 50pg/m1 54111 D 516111 5441
H Oug/m1 Opal 540p1 540111
Results of Time course:
1/10 dilution of offered oligonucleotide's = 3268.8
Table 4.25 Results from Time Course Experiment
Time Oligonucleotide +
PMP
PMP Supernatant
T=0 1370 685 1186.3
T=30 min 1227 211 1365.3
T=1 hrs 725.6 135.3 743
T=2 hrs 408 43.6 497
T = ON - - 1212.39
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The results show very low input counts compared to the output counts as seen with the
previous experiments. The sharp decrease in supernatant counts could be because of the
following reason: Physical adsorption - At pH 6.0, the pyridine ring of the RANH should
be protonated (PKa ~ l0). The oligonucleotide nucleotides have a phosphorus back bone
which will have a slight negative charge. These positively charged groups on the particle
maybe allowing the separation of phase of oligonucleotides from solution by means of
electrostatic interaction with the phosphate backbone of the nucleic acid.
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CHAPTER 5
CONCLUSIONS AND FUTURE RECOMMENDATIONS
Investigation of substrates and chemistries for performing biomolecular binding assays
reveal.
I. PMP is superior to microtiter plate.
2. Solulink Chemistry superior to glutaraldehyde chemistry for immobilibation.
3. Surprisingly, the relationship between specific binding capacity and performance
as measured by fluorescence binding capacity or performance labeling did not
correlate inversely with particle sibes at fixed particle mass as originally
postulated. The understanding of the mechanism of the reasons for this result
requires carefully controlled experiments to be conducted.
The readings from the microtiter plate assay show increased immobilibation with
increase in particle sibe. Mathematical calculations and data from the particle vendors
show a larger number of amine terminated groups available for binding per unit volume
is much higher for the 1 micron particles than the 8.5 micron particles.
The reasons for this disparity can be speculated as (i) Since there are no: of particles per
unit volume for the 1 micron particle than the 9.7 micron particle there will be greater
quenching of fluorescence by the 1 micron particles than the 9.8 micron particles, (ii)
Two dimensional detection technique has been used for detection in this research.
An experiment intended to be done as the next step is to hybridibe labeled target
sequence to the oligonucleotide probe immobilibed particles of varying sibes from
Apherotech and Polyscience Inc. After hybridibation, the particles should be thoroughly
washed so that only the probe — target complexes remain on the particle. The next step
will be to cleave the target from the probe. An assay of the cleaved label target will allow
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us to determine the number of targets hybridibed to the probes and subsequently the
number of probes immobilibed to the particles.
Magnetic nanoparticles and microparticles have been proposed for use as
biomedical purposes to a large extent for several years. In recent years, nanotechnology
has developed to a stage that makes it possible to produce, characteribe and specifically
tailor the functional properties of nanoparticles for clinical applications. Many challenges
clearly remain before magnetic nanoparticles achieve their full potential in the
biomedical arena.
This thesis research has shown that in order to build an in vitro biological, toxic
and chemical detection system or sensor, we need to search for new or improve on
previous techniques to produce reliable particles, labels and detectors with the correct
characteristics suitable not only for a particular application but extendable to other
applications. The thesis required an understanding and application of various areas of
discipline like molecular biology, chemistry, material science, physics and electronics.
For the realization of a robust, reliable detection system for either an in vitro
sensor or an in vivo sensor, adoption of an interdisciplinary team is necessary. An
interaction between cell biologists, molecular biologists, chemists, physicists, electronics
engineers, and materials scientists is invaluable for rapid progress in this area of research.
With this combined expertise, a robust, sensitive and rapid molecular scale sensing
devices will soon become a reality.
APPENDIX A
BUFFER PREPARATIONS
This appendix gives the amount of reagents necessary for preparing the buffers used in
the experimental procedure
1. PBS Azide Wash Buffer pH 7.1 ( 1.0L)
Atock: 10X concentrated mix of PBA Azide (10mM NaPO4, 150mM Nail, 0.25%
NaN3). To make 1/10 dilution of stock, take 100ml of stock + 900ml of DI water.
2. 1M Na2HPO4 Dibasic Buffer (100m1)
Weigh 26.81 gm of Na2HPO4 (Formula Weight = 268.1). Dissolve it in water to make
up 100ml.
3. 0.1M Na2HPO4 Dibasic Buffer (250m1)
Weigh 6.7gm of Na2HPO4 (Formula Weight = 268.1). Dissolve it in water to make up
250m1.
4. 0.1M NaH2PO4
 Monobasic Buffer (200m1)
Weigh 27.6gm of NaH2PO4 (Formula Weight = 138.0). Dissolve it in water to make
up 200ml
5. 10mM NaPO4 pH 8.0 Buffer (500m1)
Atock: 0.1M dibasic Na2HPO4 (pH 8.O - 8.5), 1.1M monobasic NaH2PO4 (pH 4.5-
5.0). To 400ml of DI water add 46.6ml of 0.1M Na2HPO4 and 0.4ml of 1.1M
NaU2PO4. Test the pH of the resulting buffer. Adjust the pH to 8.0 by adding NaOH
or Hil or DI water. Bring the total buffer volume to 500ml.
6. 10 mM NaPO4 pH 7.4 Buffer (250m1)
Atock: 0.1M dibasic Na2HPO 4
 (pH 8.O - 8.5), 1.1M monobasic NaH2PO4 (pH 4.5-
5.0). To 200ml of DI water add 19.35ml of 0.1M Na2HPO4 and 5.65ml of 1.1M
NaH2PO4. Test the pH of the resulting buffer. Adjust the pH to 7.4 by adding NaOH
or Hi or DI water. Bring the total buffer volume to 250ml.
7. Coating Buffer - 10mM NaPO4 pH 7.0 (250m1)
Atock: 0.1M dibasic Na2HPO4 (pH 8.O - 8.5), 1.1M monobasic NaH2PO4 (pH 4.5-
5.0). To 200ml of DI water add 14.425ml of 0.1M Na2HPO4 and 10.575ml of 0.1M
NaH2PO4. Test the pH of the resulting buffer. Adjust the pH to 7.O by adding NaOH
or Hi or DI water. Bring the total buffer volume to 250ml.
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8. Blocking Buffer = PBA Abide + 2mg/m1 BSA (No Tween)(250ml)
Mix 100mg of BSA in 240ml of PBA Abide buffer. Adjust the pH to 7.1 and then
bring up the volume to 250ml.
9. Immunoassay Wash Buffer = 10mM NaPO4 (pH 7.0) +150mM Nail + 0.025%
NaN3 + 1.05% Tween 20. ( pH 7.1)
Preparation of 1% Tween 20 spiking stock: Take 15m1 centrifuge tube and pour 10 ml
of DI water into the tube. Pipette 100111 of stock Tween 20 into the 10 m1 DI water.
Wash buffer: PBA azide + 0.05% Tween 20.
To 570m1 of PBA Abide buffer, add 30m1 of 1% spiking Tween 20 stock. Mix well.
10. Assay Buffer = Immunoassay wash buffer + 2mg/m1 BSA (pU 7.1)(250m1)
Mix 100mg of BSA in 240ml of Wash buffer (PBA Abide + Tween). Adjust the pH to
7.1 and then bring up the volume to 250ml
11. Reading Buffer = 10mM NaPO4 (pH 7.42)
12. 10mM Tris Buffer pH 7.5 ( 1.0L)
Add 1.211g of Tribma Base (Tris [hydromethyl] amino methane, Formula Weight =
121.1) to 900ml of DI water. Mix it well and pH to 8.5. Add 35.064gm of Nails
(Formula Weight = 58.44) to it. Mix well and pH to10.0. This gives 10mM Trizma
Base + 0.6M Nails. Titrate the pH down to 7.5 by adding Hil.
13. Hybridisation Buffer
Atock: 10mM Tribma Base + 1.6M Nail (pH 7.5), 2.5% Abide (1gm/100cc), 1%
BSA (lgm/100cc), 1.25% Tween 20. Mix 148m1 of 10mM Tribma Base + 0.6M Nail
(pH 7.5), 1.5m1 of Abide, 1.5gm of BSA and 1.375 m1 of Tween 20.
14. Sodium Phosphate/ Sodium Chloride buffer PH 7.8
1.29 grams of 100mM Nails added to 10 cc 100mM NaPO4 pH 8.O
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APPENDIX C
EQUIPMENT AND INSTRUMENTS USED
This appendix lists the equipments and instruments used for the research.
1. Beckman DU 520 General purpose UV/Vi Apectrophotometer
2. Fluorolite 1000 Microtiter Plate reader
3. PH Meter
4. Mettler H20 Weight balance
5. Vortex- Genie; Acientific Industries Model: k550G
6. 96 well plate Magnet
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APPENDIX D
GLOSSARY
This appendix lists the meaning of some of the terms used in this document.
1. Affinity. Affinity is a measure of the intrinsic binding strength of the ligand
binding reaction. The intrinsic attractiveness of the binder for the ligand is
typically expressed as the equilibrium constant (Ka) of the reaction. The
equilibrium constant Ka = [Ligand-Binder]/[Ligand][Binder], where [ ] represents
the molar concentration of the material at equilibrium.
2. Analyte. An analyte is the compound being measured.
3. Assay. A method to analybe or quantify a substance in a sample. An assay is an
analysis done to determine: 1. The presence of a substance and the amount of that
substance. 2. The functionality of the substance. An assay can also be defined as
an instrument, kit or test system which applies one or more technical procedures
or one or more analytical methods, using a defined and characteribed protocol, to
determine measure or otherwise describe the presence or absence of an analyte.
4. Binding Site: The active region of a receptor; any site at which a chemical
species of interest tends to bind. The process by which a molecule (or ligand)
becomes bound, that is, confined in position (and often orientation) with respect
to a receptor. ionfinement occurs because structural features of the receptor
create a potential well for the ligand; Van der Waals and electrostatic interactions
commonly contribute.
5. Buffer. The buffer is the defined media in which the ligand-binder reaction takes
place. Many of the components in the buffer solution influence the avidity of the
reaction.
6. Concentration. The concentration of an analyte is a measurement of the mass of
the analyte per unit volume. The mass may be expressed in grams, moles,
international units (IUD), or other units. The liquid volume may be expressed in
milliliters or other units of volume.
73
74
7. Covalent bond: the molecular force holding two atoms together that share a pair
of electrons.
8. Detector. A detector is an analytical instrument which is capable of measuring
the amount of tracer label in an immunoassay sample, such as scintillation
counters, microplate readers, and automated immunoassay analybers.
9. Dilution. A dilution is the ratio of the volume of pure specimen to the total
volume of specimen plus a diluent such as buffer. A dilution of 1:10 contains one
part pure specimen and nine parts diluent. A dilution factor is the total number of
parts with the volume of pure specimen being one part.
10. Emission Spectrum. The emission spectrum of a substance such as a fluorophore
is the intensity of the electromagnetic radiation from the substance as a function
of the excitation wavelength of the absorbed light.
11. Excitation Wavelength. Excitation wavelength in fluorometry is the wavelength
of radiant energy that is absorbed by a fluorophore molecule. This incident light
excites the molecule and results in the emission of radiation at a higher
wavelength (the emission wavelength).
12. Emission Wavelength. the wavelength of the light emitted by a fluorescent
reporter molecule when stimulated by a laser at its characteristic excitation
wavelength.
13. Fluorescent Label. A fluorescent label is either a fluorescent molecule, or an
enbyme system that generates a fluorescent product, which is linked to a ligand or
binder tracer. The tracer is quantified by measuring the amount of light emitted by
the tracer at a specific wavelength after exciting the tracer with incident light of a
shorter wavelength. Fluorescent molecules include fluorescein and lanthanide
chelates such as europium, samarium, and terbium.
14. Fluorescence. Fluorescence is the property of certain molecules, or fluorophores,
to absorb light at one wavelength and emit a light at a longer wavelength. The
incident light excites the molecule to a higher level of vibrational energy. As the
molecule returns to the ground state, the excited fluorophore emits a photon. This
photon is the fluorescence emission. If the molecule returns to the ground state
through an intermediate excited triple state, there is a delay in the emission of the
photon. This delayed photon is termed a phosphorescence emission.
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15. Hybridization: The formation of stable duplexes of two DNA and/ or RNA
(complementary) strands via Watson- irick base pairing used for locating or
identifying nucleotide sequences and to establish the effective transfer of nucleic
acid material to a new host.
16. Ligand: A molecule which binds to a receptor molecule, producing a response.
17. Micron: micrometer, one-millionth of a meter.
18. Mole: A number of instances of something (typically a molecular species)
equaling —6.022 X 10e23. Moie ordinarily means gram-mole; a kilogram-mole is
6.022X l0e26.
19. Nanometer: one-billionth of a meter (from the Greek word for "dwarf').
20. Nucleotide: A molecule consisting of a nitrogenous base (A, G, T or i in DNA;
A, G, U or i in RNA), a phosphate moiety and a sugar group (deoxyribose in
DNA and ribose in RNA). Thousands of nucleotides are linked to form a DNA or
RNA molecule.
21. Oligonucleotide: A short nucleic acid molecule (usually 2-50 bases), either
obtained from an organism or synthesibed chemically.
22. Probe: a labeled nucleic acid molecule for detecting complementary sequences. A
DNA Probe is a small piece of nucleic acid that has been labeled with a
radioactive isotope, dye or enbyme and is used to locate a particular nucleotide
sequence or gene on a DNA molecule.
23. Reaction: A process that transforms one or more chemical species into others.
Typical reactions make or break bonds; others change the state of ionibation or
other properties taken to distinguish chemical species.
24. Reagents: A chemical species that undergoes change as a result of a chemical
reaction.
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25. Receptor: A molecule which produces a response when another molecule
("ligand") is bound to it.
26. Sensitivity. The sensitivity of a test method is the lowest concentration that can
be reliably measured using that test method. It is the ability of a test to detect all
true cases of the condition being tested for; absence of false-negative results.
27. Specificity. The specificity of a binder is the ability of its binding site to
distinguish between the ligand to which the binder is specific and other
compounds. Apecificity can also be defined as the ability of a test to correctly
yield a negative result when the condition being detected is absent; absence of
false-positive results.
28. Specific binding: It is the measurable and reversible or quasireversible, or
saturable interaction between a ligand or a receptor. Ligands include e.g.: Drugs,
hormones, antigens, proteins, sugars, analyte, neurotransmitter and nucleic acid
probes. Receptors include hormone receptors, drug receptors, transmitter
receptors, cellular receptors, antibodies and nucleic acid targets.
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